These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 2167280
1. Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study. Bertelsen K. Gynecol Oncol; 1990 Aug; 38(2):203-9. PubMed ID: 2167280 [Abstract] [Full Text] [Related]
2. Clinical remission criteria for epithelial carcinoma of the ovary. Morikawa Y, Kawai M, Kano T, Kikkawa F, Oguchi H, Nakashima N, Ishizuka T, Furuhashi Y, Hattori SE, Kuzuya K. Gynecol Oncol; 1993 Mar; 48(3):342-8. PubMed ID: 7681806 [Abstract] [Full Text] [Related]
3. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S, Yeap B, Vogl S, Carbone P. Cancer; 1996 Feb 15; 77(4):733-42. PubMed ID: 8616766 [Abstract] [Full Text] [Related]
4. Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer. Chang SJ, Bristow RE, Ryu HS. Ann Surg Oncol; 2012 Dec 15; 19(13):4059-67. PubMed ID: 22766983 [Abstract] [Full Text] [Related]
6. [Survival in ovarian cancer treated in a gynecological department of a central hospital]. Dragsted NO, Nørgaard M, Bøsling KB. Ugeskr Laeger; 1997 May 12; 159(20):3003-9. PubMed ID: 9190729 [Abstract] [Full Text] [Related]
8. The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma. Piver MS, Lele SB, Marchetti DL, Baker TR, Tsukada Y, Emrich LJ. J Clin Oncol; 1988 Jun 12; 6(6):983-9. PubMed ID: 3373267 [Abstract] [Full Text] [Related]
9. Treatment of advanced ovarian carcinoma with hexamethylmelamine, doxorubicin, and cis-platinum (HAC): results in both untreated and previously treated patients. Brower MS, Coleman M, Pasmantier MW, Silver RT, Mamaril AP, Quiguyan CC. Med Pediatr Oncol; 1984 Jun 12; 12(1):17-24. PubMed ID: 6321930 [Abstract] [Full Text] [Related]
10. [Effect of chemotherapy on the prognosis of ovarian cancer]. Sugawa T, Umesaki N, Yajima A, Satoh S, Terashima Y, Ochiai K, Tomoda Y, Kanoh T, Noda K, Yakushiji M. Nihon Sanka Fujinka Gakkai Zasshi; 1992 Sep 12; 44(9):1135-41. PubMed ID: 1333504 [Abstract] [Full Text] [Related]
11. A prospective randomized comparison of 6 and 12 cycles of cyclophosphamide, adriamycin, and cisplatin in advanced epithelial ovarian cancer: a Danish Ovarian Study Group trial (DACOVA). Bertelsen K, Jakobsen A, Strøyer J, Nielsen K, Sandberg E, Andersen JE, Ahrons S, Nyland M, Hjortkjaer Pedersen P, Larsen G. Gynecol Oncol; 1993 Apr 12; 49(1):30-6. PubMed ID: 8482557 [Abstract] [Full Text] [Related]
12. Chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide as an adjunct to surgery in stage Ic-II epithelial ovarian carcinoma. Gynecologic Oncology Group of the Comprehensive Cancer Center. Wils J, van Geuns H. Am J Clin Oncol; 1989 Jun 12; 12(3):251-4. PubMed ID: 2658540 [Abstract] [Full Text] [Related]
13. Primary or delayed debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide in stage III-IV epithelial ovarian carcinoma. Wils J, Blijham G, Naus A, Belder C, Boschma F, Bron H, Ceelen T, Eekhout A, von Erp J, Geelen P. J Clin Oncol; 1986 Jul 12; 4(7):1068-73. PubMed ID: 3723166 [Abstract] [Full Text] [Related]
14. Role of neoadjuvant chemotherapy in the management of advanced ovarian cancer. Zhao D, Wu LY, Wang XB, Li XG. Asian Pac J Cancer Prev; 2015 Jul 12; 16(6):2369-73. PubMed ID: 25824766 [Abstract] [Full Text] [Related]
15. Long-term follow-up of patients with advanced ovarian carcinoma treated with debulking surgery and chemotherapy consisting of cisplatin, doxorubicin, and cyclophosphamide. Gynecologic Oncology Group of the Comprehensive Cancer Center. Wils JA. Oncology; 1990 Jul 12; 47(2):115-20. PubMed ID: 2107480 [Abstract] [Full Text] [Related]
16. Neoadjuvant chemotherapy, interval debulking surgery or primary surgery in ovarian carcinoma FIGO stage IV? Tropé CG, Elstrand MB, Sandstad B, Davidson B, Oksefjell H. Eur J Cancer; 2012 Sep 12; 48(14):2146-54. PubMed ID: 22382201 [Abstract] [Full Text] [Related]
17. Cisplatin, methotrexate, and 5-fluorouracil combination chemotherapy for advanced ovarian cancer. Conte PF, Sertoli MR, Bruzzone M, Rubagotti A, Rosso R, Bentivoglio G, Conio A, Pescetto G. Gynecol Oncol; 1985 Mar 12; 20(3):290-7. PubMed ID: 2982705 [Abstract] [Full Text] [Related]
18. Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Pectasides D, Fountzilas G, Aravantinos G, Kalofonos HP, Efstathiou E, Salamalekis E, Farmakis D, Skarlos D, Briasoulis E, Economopoulos T, Dimopoulos MA. Gynecol Oncol; 2005 May 12; 97(2):436-41. PubMed ID: 15863142 [Abstract] [Full Text] [Related]
19. Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide. Colozza M, Mosconi AM, Gori S, Belsanti V, Basurto C, De Angelis V, Giansanti M, Tonato M. Am J Clin Oncol; 1997 Oct 12; 20(5):522-6. PubMed ID: 9345342 [Abstract] [Full Text] [Related]
20. [The therapeutic value of second-look laparotomy in advanced ovarian carcinoma]. Schneider J, Martin M, Erasun F, Matia JC, Rodriguez-Escudero FJ. Zentralbl Gynakol; 1988 Oct 12; 110(22):1443-8. PubMed ID: 3223119 [Abstract] [Full Text] [Related] Page: [Next] [New Search]